TESTOVA BASE
Fast-acting testosterone suspension 100 mg/ml for immediate hormonal support and anabolic activity.
CAS Number: 58-22-0
Testova Base is indicated for male hypogonadism, low testosterone levels, delayed puberty, and hormone imbalance. Its water-based formulation ensures rapid testosterone absorption and immediate anabolic effects under medical supervision.
TESTOVA BASE by Nova Techsciences is an injectable testosterone suspension containing Testosterone Base at 100 mg/ml. Unlike esterified testosterone compounds, Testosterone Base does not contain an attached ester. The Nova Techsciences product page identifies the active compound with CAS Number 58-22-0 and describes the formulation as water-based.
This product information is intended to explain the identity, formulation, quality requirements and safety considerations associated with TESTOVA BASE. It does not replace an authorised Summary of Product Characteristics, prescribing information or advice from a qualified healthcare professional.
TESTOVA BASE Product Overview
As a non-esterified testosterone formulation, TESTOVA BASE has a different pharmaceutical profile from Testosterone Propionate, Testosterone Phenylpropionate and Testosterone Cypionate. These products should not be considered interchangeable, because their formulations, concentrations and release characteristics are different.
Important product details include:
- Product name: TESTOVA BASE
- Active compound: Testosterone Base
- Strength: 100 mg/ml
- Dosage form: Injectable testosterone suspension
- CAS Number: 58-22-0
- Brand: Nova Techsciences
The product label should clearly state the complete composition, excipients, administration route, storage conditions, batch number, manufacturing date and expiry date.
Quality, Testing and Traceability
Every TESTOVA BASE batch should be supported by appropriate quality-control documentation. Relevant checks may include active-ingredient identification, concentration testing, impurity analysis, sterility testing, microbiological examination, particulate assessment and container-closure integrity.
Nova Techsciences should ensure that information published on the website is consistent with the vial, outer packaging, catalogue and Certificate of Analysis. For the UK, Netherlands and other European markets, product information should also clearly communicate its marketing-authorisation status, legal supply category and adverse-event reporting process.
Safety Information
Testosterone is an anabolic-androgenic steroid and prescription-only medicine in the United Kingdom. Unsupervised anabolic-steroid use can cause serious hormonal, cardiovascular, reproductive, liver, kidney and psychological effects.
TESTOVA BASE should only be used where legally authorised and under qualified medical supervision. It should not be promoted for self-medication, unsupervised bodybuilding or use by minors. Patients with prostate or breast cancer, cardiovascular disease, liver or kidney disorders, polycythaemia or sensitivity to any formulation ingredient require professional medical assessment.
Related Nova Techsciences Products
STANOVA 10
STANOVA 10 is a tablet formulation containing Stanozolol 10 mg, associated with CAS Number 10418-03-8. It is a separate anabolic-androgenic compound and has different formulation, liver-related safety considerations and contraindications from injectable testosterone products.
SUSTOVA
SUSTOVA is presented as a Testosterone Blend 250 mg/ml injectable. Because it combines testosterone components, the identity and strength of every ester should be confirmed through its current label and batch documentation before the product is supplied or professionally assessed.
TESTOVA P
TESTOVA P contains Testosterone Propionate 100 mg/ml and is identified with CAS Number 57-85-2. The propionate ester distinguishes this product from non-esterified TESTOVA BASE and requires separate prescribing, monitoring, storage and quality documentation.
TESTOVA PP
TESTOVA PP is a Testosterone Phenylpropionate 100 mg/ml injectable with CAS Number 1255-49-8. Its short ester formulation has a different pharmaceutical profile from Testosterone Base, Propionate and Cypionate and should only be considered under licensed professional supervision.
TESTOVA C
TESTOVA C contains Testosterone Cypionate 250 mg/ml and carries CAS Number 58-20-8. It is an esterified testosterone formulation requiring clear batch traceability, appropriate hormonal monitoring, verified contraindication information and compliance with applicable pharmaceutical regulations.
TESTOVA BASE should ultimately be presented through accurate chemical identification, transparent quality documentation and responsible safety communication. This approach gives healthcare professionals, distributors and regulatory reviewers clearer information about the Nova Techsciences product.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Use only under qualified medical supervision.
- Monitor testosterone levels, liver function, lipid profile, and blood pressure regularly.
- May suppress natural testosterone production.
- Risk of estrogen conversion (aromatization).
- Not recommended for long-term unsupervised use.
Contraindications
- Do not use if allergic to testosterone or injection components.
- Contraindicated in patients with prostate or breast cancer, severe cardiac, liver, or kidney disease, polycythemia, pregnant or breastfeeding women, or children without confirmed hormonal deficiency.
Related Products
BOLDENOVA
Boldenone Undecylenate 250 mg/ml injection for lean bulking, endurance, and performance enhancement.
DROSTANOVA P
Dry, anti-estrogenic Drostanolone Propionate 100 mg/ml injectable for cutting, muscle hardening, and strength enhancement.
NANDROVA D
Nandrolone Decanoate 250 mg/ml injection for lean bulking, recovery, and joint support.
NANDROVA P
Fast-acting Nandrolone Phenylpropionate 100 mg/ml injection for muscle recovery, nitrogen retention, and rehabilitation.